
Durham Uni research predicts more Milky Way satellite galaxies
She said that if the galaxies were seen by a telescope it would help support the Lambda Cold Dark Matter (LCDM) theory, which would have "a big significance for the whole community".It is used to explain the large-scale structure of the Universe and proposes there should be many small galaxies.LCDM also suggests 25% of the Universe is cold dark matter."In other models where the particle mass is different, we do not expect that many satellites," Dr Santos-Santos said."So, even if we find them, or if we don't, the implications are very strong for the whole community of cosmologists and astrophysicists in knowing what is the dark matter particle."
According to the LCDM model, galaxies form in the centre of gigantic clumps of dark matter called halos. The new research shows that the Milky Way's missing satellites are extremely faint galaxies stripped almost entirely of their parent dark matter halos by the gravity of the Milky Way's halo. These so-called "orphan" galaxies are lost in most simulations, but should have survived in the real Universe.It is hoped new advances in telescopes and instruments like the Rubin Observatory LSST camera will give astronomers the ability to detect these very faint objects."We expect that in the next five years we will be able to confirm, to test if these satellite galaxies that we are predicting are really there or not," Dr Santos-Santos said.
Dr Santos-Santos said previous work had used simulations with lower resolution and could only predict a certain number of galaxies with a certain mass.The Durham researchers used the Aquarius simulation and the GALFORM model, a code developed at Durham over the past two decades.The findings are being presented on Friday at the Royal Astronomical Society's National Astronomy Meeting, being held at Durham University.
Follow BBC North East on X, Facebook, Nextdoor and Instagram.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
7 minutes ago
- The Independent
The eating habits that could lower your risk of diabetes
Research indicates that several healthy diets can significantly reduce the risk of type 2 diabetes, irrespective of a person's ethnicity. An analysis by University of Cambridge researchers, involving 826,000 people across 33 studies, examined the Dash, Mediterranean, and Alternative Healthy Eating Index (AHEI) diets. Adherence to these dietary patterns led to substantial reductions in type 2 diabetes risk: Dash by 23 per cent, Mediterranean by 17 per cent, and AHEI by 21 per cent. The study found that the benefits of these diets were consistent across African, Asian, European, and Hispanic ethnic groups, suggesting universal applicability. These findings strengthen the evidence that such dietary patterns can be promoted across all populations to reduce type 2 diabetes risk.


Reuters
8 minutes ago
- Reuters
Musk's Neuralink to launch a clinical study in Great Britain
July 31 (Reuters) - Elon Musk's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its chips can enable patients with severe paralysis to control digital and physical tools with their thoughts.


Reuters
8 minutes ago
- Reuters
Musk's Neuralink to test brain chips in clinical study in Great Britain
July 31 (Reuters) - Elon Musk's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its chips can enable patients with severe paralysis to control digital and physical tools with their thoughts. The company is partnering with the University College London Hospitals trust and Newcastle Hospitals to conduct the study, it said in a post on X. Neuralink said patients living with paralysis due to conditions such as spinal cord injury and a nervous system disease called Amyotrophic Lateral Sclerosis (ALS) qualify to participate in the study. The company raised $650 million in its latest funding round last month. It began human trials in 2024 on its brain implant after resolving safety concerns flagged by the U.S. Food and Drug Administration, which had initially rejected Neuralink's application in 2022. According to the company, five patients with severe paralysis are currently using its device to control digital and physical tools with their thoughts. Neuralink, founded in 2016, has raised about $1.3 billion from investors and is valued at roughly $9 billion, according to media reports, citing PitchBook.